Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. [electronic resource]
Producer: 20090928Description: 704-17 p. digitalISSN:- 1523-6536
- Acute Disease
- Adolescent
- Adult
- Antilymphocyte Serum -- administration & dosage
- Chronic Disease
- Disease-Free Survival
- Female
- Graft vs Host Disease -- epidemiology
- HLA Antigens -- analysis
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Histocompatibility
- Humans
- Incidence
- Leukemia, Myeloid -- mortality
- Living Donors
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Prospective Studies
- Survival Analysis
- T-Lymphocytes -- immunology
- Tacrolimus -- administration & dosage
- Transplantation Conditioning
- Transplantation, Homologous -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.